HDAC4 and serous adenocarcinoma: In the univariate survival analysis for overall survival, only HDAC-4 immunopositivity in serous carcinomas seemed to be associated with a better OS, which was a correlation of marginal significance only (log-rank test, p = 0.086, Figure 4).